The influence of CYP2C19 polymorphism on the eradication of Helicobacter pylori:: A randomized study of lansoprazole and rabeprazole

被引：0
作者：
Jung, H. Y. [1 ]
Song, H. J. [1 ]
Choi, K. D. [1 ]
Chung, J. W. [1 ]
Kim, D. H. [1 ]
Kim, J. H. [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
来源：
HELICOBACTER | 2007年 / 12卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：429 / 429
页数：1
相关论文
共 50 条
  • [41] The effect of genetic differences in CYP2C19 on cure rates for Helicobacter pylori by dual therapy with rabeprazole and amoxicillin
    Furuta, T
    Ohashi, K
    Takashima, M
    Shirai, N
    Kosuge, K
    Ishizaki, T
    Kaneko, E
    GASTROENTEROLOGY, 1999, 116 (04) : A167 - A167
  • [42] CYP2C19 polymorphism has no influence on rabeprazole-based sequential or hybrid therapy
    Lin, T. J.
    Lin, C. L.
    Lee, H. C.
    Wang, C. K.
    Chen, K. Y.
    Wu, D. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 118 - 118
  • [43] Randomized trial comparing rabeprazole- versus lansoprazole-based Helicobacter pylori eradication regimens
    Liu, Meng-Kwan
    Wu, I-Chen
    Lu, Chien-Yu
    Kuo, Chao-Hung
    Yu, Fang-Jung
    Liu, Chung-Jung
    Hsu, Ping-I
    Hsu, Wen-Hung
    Su, Yu-Chung
    Chen, Angela
    Wu, Deng-Chyang
    Kuo, Fu-Chen
    Chen, Jyh-Jou
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2013, 29 (07) : 379 - 384
  • [44] Influence of smoking and CYP2C19 genotypes on H-pylori eradication success
    Suzuki, T.
    Matsuo, K.
    Sawaki, A.
    Wakai, K.
    Hirose, K.
    Ito, H.
    Saito, T.
    Nakamura, T.
    Yamao, K.
    Hamajima, N.
    Tajima, K.
    EPIDEMIOLOGY AND INFECTION, 2007, 135 (01) : 171 - 176
  • [45] The correlation of CYP2C19 genetic polymorphisms to Helicobacter pylori eradication in cirrhotic patients with peptic ulcer
    Lay, C-S
    Lin, J-R
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A20 - A20
  • [46] Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype
    Mitsushige Sugimoto
    Takahisa Furuta
    World Journal of Gastroenterology, 2014, (21) : 6400 - 6411
  • [47] Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients
    Kurzawski, Mateusz
    Gawronska-Szklarz, Barbara
    Wrzesniewska, Joanna
    Siuda, Andrzej
    Starzynska, Teresa
    Drozdzik, Marek
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (10) : 877 - 880
  • [48] CYP2C19 genotype status and intragastric pH during lansoprazole and rabeprazole treatment.
    Kawamura, A
    Adachi, K
    Katsube, T
    Ishihara, S
    Watanabe, M
    Kinoshita, Y
    GASTROENTEROLOGY, 2000, 118 (04) : A1086 - A1086
  • [49] Effect of lansoprazole and rabeprazole on intragastric,acidity in relation to CYP2C19 genotype status.
    Sukegawa, M
    Hokari, K
    Takeda, H
    Sugiyama, T
    Kato, M
    Asaka, M
    GASTROENTEROLOGY, 2000, 118 (04) : A1310 - A1310
  • [50] Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients
    Mateusz Kurzawski
    Barbara Gawrońska-Szklarz
    Joanna Wrześniewska
    Andrzej Siuda
    Teresa Starzyńska
    Marek Droździk
    European Journal of Clinical Pharmacology, 2006, 62 : 877 - 880
12345